Logo
x

Search

Subscribe Now

NeuroBo Pharmaceuticals

Neurobo Pharmaceuticals Reports First Patient Dosing in P-I Study of DA-1726 to Treat Obesity

Neurobo Pharmaceuticals Reports First Patient Dosing in P-I Study of DA-1726 to Treat Obesity

  • June 27, 2024
NeuroBo Pharmaceuticals Reports IND Submission to the US FDA for Conducting P-I Study of DA-1726 to Treat Obesity

NeuroBo Pharmaceuticals Reports IND Submission to the US FDA for Conducting P-I Study of DA-1726 to Treat Obesity

  • January 1, 2024
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.